Proactive hypertension risk detection on the Apple Watch Series 10—advanced health technology designed for comprehensive wellness monitoring.
Apple has launched a new health feature on Apple Watch that helps users assess their risk of hypertension, now available in Canada.
This feature uses advanced sensing technology to monitor potential indicators of hypertension by analyzing blood vessel responses to heartbeats over a 30-day period. It is not a substitute for clinical blood pressure measurement but offers early insights into vascular health trends.
"Globally, over 1 billion people live with hypertension, nearly half unaware of their condition. This feature supports early detection and proactive health management." — Apple
The hypertension risk detection feature is available on the following Apple Watch models:
Note: The 2025 Apple Watch SE does not support this feature.
Model | Storage Size | Price | Original Price |
---|---|---|---|
Apple Watch Series 10 [GPS, 46mm] | — | $413.99 | $589.99 |
Apple Watch Series 10 [GPS, 46mm] | — | $406.99 | $549.99 |
Apple Watch Series 10 [GPS, 46mm] | — | $413.99 | $589.99 |
Apple Watch Series 10 [GPS, 46mm] | — | $413.99 | $589.99 |
Apple Watch Series 10 [GPS, 46mm] | — | $413.99 | $589.99 |
Apple Watch Series 10 [GPS, 46mm] | — | $413.99 | $589.99 |
All prices are in Canadian dollars (CAD). Variations reflect pricing across different retailers.